Osteoporosis
Best Practice & Research Compendium
- 1st Edition
- Authors: Cyrus Cooper, Anthony D. Woolf
- Language: English
This prestigious text offers the most up-to-date advice on the identification and management of osteoporosis. Derived from the highly acclaimed journals Best Practice and Research… Read more
Purchase options
This prestigious text offers the most up-to-date advice on the identification and management of osteoporosis. Derived from the highly acclaimed journals Best Practice and Research – Clinical Endocrinology & Metabolism and Best Practice and Research – Rheumatology this fully updated volume provides a logical progression through definition, diagnosis, epidemiology, as well as the latest advice on disease prevention, treatment and screening.
Fully illustrated throughout, the book draws upon the expertise of some of the world’s leading experts in the field, providing a publication that gives a truly international perspective to the management of osteoporosis.
Key features include:
• Full reference to the latest clinical research;
• New chapters on risk assessment and the cost-effectiveness of interventions for the prevention and treatment of osteoporosis;
• Cochrane Reviews, when relevant;
• The provision of boxed and bulleted Research Agenda and Practice Points;
• Reference to national and international guidelines.
Also suitable for biochemists and other research scientists, Best Practice and Research Compendium: Osteoporosis comprises a comprehensive review of the leading practice and research to date, helping ensure that the specialist has all the most essential information about osteoporosis readily to hand.
Fully illustrated throughout, the book draws upon the expertise of some of the world’s leading experts in the field, providing a publication that gives a truly international perspective to the management of osteoporosis.
Key features include:
• Full reference to the latest clinical research;
• New chapters on risk assessment and the cost-effectiveness of interventions for the prevention and treatment of osteoporosis;
• Cochrane Reviews, when relevant;
• The provision of boxed and bulleted Research Agenda and Practice Points;
• Reference to national and international guidelines.
Also suitable for biochemists and other research scientists, Best Practice and Research Compendium: Osteoporosis comprises a comprehensive review of the leading practice and research to date, helping ensure that the specialist has all the most essential information about osteoporosis readily to hand.
- Full reference to the latest clinical research
- New chapters on risk assessment and the cost-effectiveness of interventions for the prevention and treatment of osteoporosis
- Cochrane Reviews, when relevant
- The provision of boxed and bulleted Research Agenda and Practice Points
- Reference to national and international guidelines
Epidemiology of osteoporosis
Fractures in the elderly: epidemiology and demography
Pathogenesis of osteoporosis
Prenatal and childhood influences on osteoporosis
Corticosteroid osteoporosis
Lower peak bone mass and its decline
The role of bone turnover markers and risk factors
in the assessment of osteoporosis and fracture risk
The use of bone densitometry in clinical practice
Role of biochemical markers in the management of osteoporosis
Glucocorticoid-induced osteoporosis
Osteoporosis in men
Osteoporosis in childhood diseases: prevention and therapy
Post-menopausal osteoporosis
How to prevent fractures in the individual with osteoporosis
Non-pharmacological interventions
Phyto-oestrogens
Oestrogen and selective receptor modulators
(SERMS): current roles in the prevention and treatment of osteoporosis
Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis
Biologic therapies in osteoporosis
Anabolic bone binding treatment [PTH] analogues and strontium
Cost utility of treatment of osteoporosis
Risk assessment in osteoporosis
Future methods in the assessment of bone mass and structure
Fractures in the elderly: epidemiology and demography
Pathogenesis of osteoporosis
Prenatal and childhood influences on osteoporosis
Corticosteroid osteoporosis
Lower peak bone mass and its decline
The role of bone turnover markers and risk factors
in the assessment of osteoporosis and fracture risk
The use of bone densitometry in clinical practice
Role of biochemical markers in the management of osteoporosis
Glucocorticoid-induced osteoporosis
Osteoporosis in men
Osteoporosis in childhood diseases: prevention and therapy
Post-menopausal osteoporosis
How to prevent fractures in the individual with osteoporosis
Non-pharmacological interventions
Phyto-oestrogens
Oestrogen and selective receptor modulators
(SERMS): current roles in the prevention and treatment of osteoporosis
Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis
Biologic therapies in osteoporosis
Anabolic bone binding treatment [PTH] analogues and strontium
Cost utility of treatment of osteoporosis
Risk assessment in osteoporosis
Future methods in the assessment of bone mass and structure
- Language: English
- Edition: 1
- Published:
- Imprint: Elsevier
CC
Cyrus Cooper
Affiliations and expertise
Director and Professor of Rheumatology, Southampton General Hospital, Southampton, UKAW
Anthony D. Woolf
Affiliations and expertise
Professor of Rheumatology, Department of Rheumatology, Royal Cornwall Hospital, Truro, UK